Showing 1 of 1 recruiting trials for “Juvenile nasopharyngeal angiofibroma”
Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal Angiofibroma (JNA)
🏥 Federal Research Institute of Pediatric Hematology, Oncology and Immunology📍 1 site📅 Started May 2022View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →